We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current CRMD market cap is 694.57M. The company's latest EPS is USD -0.7637 and P/E is -14.77.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 806k | 11.46M |
| Operating Income | -10.47M | -15.67M | -16.7M | -15.3M | -3.29M |
| Net Income | -9.74M | -14.75M | -14.47M | -14.15M | -2.78M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 283k | 239k | 191k | 65k | 0 |
| Operating Income | -21.01M | -27.22M | -29.44M | -30.62M | -48.96M |
| Net Income | -16.43M | -22.03M | -28.21M | -29.7M | -46.34M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 91.43M | 82.06M | 68.02M | 57.73M | 77.59M |
| Total Liabilities | 8.23M | 11.92M | 10.01M | 11.55M | 18.87M |
| Total Equity | 83.2M | 70.14M | 58.01M | 46.18M | 58.71M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 29.48M | 49.31M | 68.95M | 62.04M | 82.06M |
| Total Liabilities | 5.83M | 5.09M | 6.15M | 6.98M | 11.92M |
| Total Equity | 23.65M | 44.22M | 62.8M | 55.06M | 70.14M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -27.66M | -38.41M | -17.31M | -31.35M | -45M |
| Investing | -17.66M | -17.06M | 8.95M | 15.21M | 21.54M |
| Financing | 55.45M | 55.92M | -97k | 960k | 15.03M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -15.05M | -21.97M | -21.16M | -24.36M | -38.41M |
| Investing | -12.02M | 7.43M | -9.14M | -3.71M | -17.06M |
| Financing | 25.8M | 40.1M | 41.76M | 17.9M | 55.92M |
| Market Cap | 694.57M |
| Price to Earnings Ratio | -14.77 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 15.68 |
| Price to Book Ratio | 9.76 |
| Dividend Yield | - |
| Shares Outstanding | 60.68M |
| Average Volume (1 week) | 1.25M |
| Average Volume (1 Month) | 1.55M |
| 52 Week Change | 245.83% |
| 52 Week High | 13.85 |
| 52 Week Low | 2.89 |
| Spread (Intraday) | 0.23 (2.03%) |
| Company Name | CorMedix Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.cormedix.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
